Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

13

Sep 2019

Hansen Pharmaceuticals and Atomwise Launch Strategic Collaboration on Artificial Intelligence Drug Discovery in Multiple Therapeutic Areas

Chinas leading biopharmaceutical company Hansoh Pharmaceutical Group Company Limited Hansen Pharmaceutical and drug discovery artificial intelligence AI Atomwise Inc Atomwise a leader in the field announced a collaborative design and discovery of potential drug candidates for up to unexposed t...

13

Sep 2019

Castle Creek Pharmaceutical Holdings Announces Agreement to Acquire Fibrocell

Castle Creek Pharmaceutical Holdings Inc CCP Holdings today announced it has reached an agreement to acquire Fibrocell Science Inc Nasdaq FCSC a cell and gene therapy company focused on transformational autologous cellbased therapies for skin and connective tissue diseases

12

Sep 2019

Dance Biopharm Partners With DarioHealth to Expand Access to Digital Therapeutics Platform for Patients With Chronic Diseases

Dance Biopharm Holdings Inc a clinicalstage company reimagining the treatment of chronic diseases with inhaled therapies announced today it has formed a strategic alliance with DarioHealth Corp Dario a leading global digital therapeutics company to expand access to a personalized digital health mana...

12

Sep 2019

Hansoh Pharma and Atomwise Launch Strategic AI Drug Discovery Collaboration for Multiple Therapeutic Areas

Hansoh Pharmaceutical Group Company Limited Hansoh Pharma a leading biopharmaceutical company in China and Atomwise Inc Atomwise the leader in artificial intelligence AI for drug discovery have announced a collaboration to design and discover potential drug candidates for up to eleven undisclosed ta...

press releasesRead more...

13

Sep 2019

Phillips-Medisize Enters Agreement with Global Pharmaceutical Company to Acquire Exclusive Ownership of Patents for an Innovative Mini-tablet Dispenser

PhillipsMedisize a Molex company announced today an agreement with a Global Pharmaceutical Company where PhillipsMedisize acquired exclusive ownership of patents supporting an innovative minitablet dispenser to accommodate the varied and customized oral dispensing needs of patients

13

Sep 2019

Aytu BioScience Announces Definitive Agreement to Acquire Innovus Pharmaceuticals

Aytu BioScience Inc a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs and Innovus Pharmaceuticals Inc OTCQB INNV a specialty pharmaceutical company commercializing licensing and developing safe and effective consumer health products t...

13

Sep 2019

Orion Biotechnology to Initiate Clinical Trials of Its Innovative Microbicide Gel for HIV Prevention

Orion Biotechnology Canada Ltd today announced that the Polish National Regulatory Agency and Local Ethics Committee have given approval for the OBH Phase safety and acceptability study of OBH gel to start screening and enrollment The OBH gel is a topical formulation of OB PRANTES a novel chemokine...

12

Sep 2019

Athenex Announces Initiation of Phase I Clinical Study in China of KX2-361 Oral by Partner Guangzhou Xiangxue Pharmaceutical

Athenex Inc a global biopharmaceutical company dedicated to the discovery development and commercialization of novel therapies for the treatment of cancer and related conditions today announced that its partner Guangzhou Xiangxue Pharmaceutical Co Ltd initiated a Phase I study in China of KX formerl...

EventsRead more...

16 - 18

Sep 2019

Future Laboratory Informatics Forum 2019

Mercure Hotel Amsterdam City

16 - 17

Sep 2019

Human Physiology 2019

Lexis Conferences
London

16 - 18

Sep 2019

CPhI Middle East & Africa 2019

Abu Dhabi National Exhibition Centre

16 - 19

Sep 2019

Trial Master Files and Inspection Readiness Summit

Pullman Brussels Centre Midi Hotel

16 - 16

Sep 2019

Mobile in Clinical Trials 2019

Renaissance Boston Waterfront Hotel

17 - 19

Sep 2019

Advertisements

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    Merck

    Staff Engineer, Manufacturing Science and Technology, South East Asia

    Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot...

EDITORIAL SECTION

  • STRATEGY

    REDUCTION OF HEALTH COSTS

    Since autumn the first package of costcutting measures in Switzerlands healthcare system is being reviewed One of the measures is the socalled refere...